Wells Fargo’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | -$1 | – | 6597 |
|
|
2024
Q2 | – | Sell |
-4
| Closed | -$57 | – | 6469 |
|
|
2024
Q1 | $57 | Buy |
4
+2
| +100% | +$29 | ﹤0.01% | 6399 |
|
|
2023
Q4 | $25 | Buy |
2
+1
| +100% | +$13 | ﹤0.01% | 6706 |
|
|
2023
Q3 | $24 | Hold |
1
| – | – | ﹤0.01% | 6769 |
|
|
2023
Q2 | $63 | Hold |
1
| – | – | ﹤0.01% | 6683 |
|
|
2023
Q1 | $89 | Hold |
1
| – | – | ﹤0.01% | 6640 |
|
|
2022
Q4 | $197 | Buy |
+1
| New | +$197 | ﹤0.01% | 6298 |
|
|
2022
Q3 | – | Hold |
0
| – | -$1K | – | 7167 |
|
|
2022
Q2 | – | Hold |
0
| – | -$6K | – | 6339 |
|
|
2022
Q1 | – | Hold |
0
| – | -$8K | – | 6081 |
|
|
2021
Q4 | – | Hold |
0
| – | -$16K | – | 6079 |
|
|
2021
Q3 | – | Hold |
0
| – | -$46K | – | 5729 |
|
|
2021
Q2 | – | Hold |
0
| – | -$75K | – | 5275 |
|
|
2021
Q1 | – | Hold |
0
| – | -$54K | – | 5274 |
|
|
2020
Q4 | – | Hold |
0
| – | -$40K | – | 5370 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5329 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6484 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6452 |
|